Research Output per year
Personal profile
Research Interests
Our research strategically focuses on deciphering the molecular mechanisms linking nutritional signalling (e.g. high-fat/high-carbohydrate diet and functional foods) with the onset of chronic metabolic disease, including diabetes, non-alcoholic fatty liver disease, cardiovascular disease and inflammatory bowel disease.
We employ a wide range of laboratory approaches from in vivo physiology to molecular biology and cell culture, such as genetically engineered animal models, Crispr/cas9 gene editing, single cell RNA-sequencing and microRNA profiling, to investigate the underlying molecular mechanisms that link lipid/carbohydrate metabolism and gut microbiomes with the pathogenesis of metabolic syndrome. We further investigate the therapeutic potentials of functional food (i.e. Fenugreek) and identify pharmaceutical targets that may lend supports for the prevention and treatment of diabetes, non-alcoholic fatty liver disease and cardiovascular disease.
Fingerprint Dive into the research topics where Qiaozhu Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
Bioactive Compounds in Fenugreek Ameliorate ER Stress and VLDL Overproduction via the Mediation of Insig Signaling
Khound, R. & Su, Q., 12 Mar 2018, In : Arteriosclerosis Thrombosis and Vascular Biology. 38, Suppl_1, p. A178 1 p.Research output: Contribution to journal › Meeting abstract
MicroRNAs and Hedgehog Signaling in the Pathogenesis of Progressive Liver Injury from NAFLD to Fibrosis
Cheng, X. & Su, Q., 12 Mar 2018, In : Arteriosclerosis Thrombosis and Vascular Biology. 38, Suppl_1, p. A601 1 p.Research output: Contribution to journal › Meeting abstract
18
Citations
(Scopus)
MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
Su, Q., Kumar, V., Sud, N. & Mahato, R. I., Apr 2018, In : Advanced Drug Delivery Reviews. 129, p. 54-63 10 p.Research output: Contribution to journal › Review article
21
Citations
(Scopus)
Novel peptide dermaseptin‐PS1 exhibits anticancer activity via induction of intrinsic apoptosis signalling
Long, Q., Li, L., Wang, H., Li, M., Wang, L., Zhou, M., Su, Q., Chen, T. & Wu, Y., 21 Nov 2018, In : Journal of Cellular and Molecular Medicine. 23, 2, p. 1300-1312 13 p.Research output: Contribution to journal › Article
Open Access
File
2
Citations
(Scopus)
177
Downloads
(Pure)
Aberrant Expression of MicroRNA-378a Induces Hepatic Insulin Resistance via Activation of ER Stress and the dsRNA Activated Protein Kinase PKR
Cheng, X. & Su, Q., 25 Aug 2017, In : Arteriosclerosis Thrombosis and Vascular Biology. 37, Suppl_1, p. A552 1 p.Research output: Contribution to journal › Meeting abstract
Prizes
2nd place winner in research competition
Su, Qiaozhu (Recipient), 01 Oct 2018
Prize: Prize (including medals and awards)
Fellow of the American Heart Association (FAHA)
Su, Qiaozhu (Recipient), 06 Nov 2019
Prize: National/international honour
Paul Dudley White International Scholar Award
Su, Qiaozhu (Recipient), 06 May 2020
Prize: Prize (including medals and awards)
Activities
Advanced Drug Delivery Reviews (Journal)
Qiaozhu Su (Guest editor)
01 May 2020 → 30 Apr 2021
Activity: Publication peer-review and editorial work types › Editorial activity
Gut-Derived Metabolite Trimethylamine Regulates NFB Signaling and Lipoprotein Metabolism: A Potential Therapeutic Target for Atherosclerosis
Qiaozhu Su (Invited speaker)
05 May 2020
Activity: Talk or presentation types › Oral presentation
Therapeutic Potentials of MicroRNAs and Gut Microbiome in NAFLD and Insulin Resistance
Qiaozhu Su (Invited speaker)
05 Sep 2019
Activity: Talk or presentation types › Invited talk
MicroRNAs and Gut Microbiome in Cardiovascular Disease and NAFLD
Qiaozhu Su (Invited speaker)
25 Jul 2019
Activity: Talk or presentation types › Invited talk
British Journal of Nutrition (Journal)
Qiaozhu Su (Peer reviewer)
21 Apr 2019
Activity: Publication peer-review and editorial work types › Publication peer-review